MENU
ANRO
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Alto Neuroscience (ANRO) Ownership - Who owns Alto Neuroscience?
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals’ neurobiology to develop personalized and effective treatment options... Show more
Profile
Industry
N/A
Address
369 South San Antonio Road
Phone
+1 650 200-0412
Employees
63
Web
https://www.altoneuroscience.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
61.18M
P/E Ratio
N/A
Total Cash
168.23M
Projected Growth
N/A
Total Debt
16.94M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.21
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ANRO
Capitalization
61.2M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
168M
Total Cash/Share
6.21
Total Debt
16.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
151M
P/B Ratio
0.40
Cash Flow
N/A
Earnings
-2.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
16.92
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-59.55M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-46.51
Shares Held By Institutions
116M
Shares Outstanding - Current
27.1M
Total Liabilities
26.1M
Total Volume MTD
N/A
Value
1
Gain YTD
-46.572
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
369 South San Antonio Road
Phone
+1 650 200-0412
Employees
63
Web
https://www.altoneuroscience.com